Pilotto, Alberto, Polidori, Maria Cristina, Veronese, Nicola ORCID: 0000-0002-9328-289X, Panza, Francesco ORCID: 0000-0002-7220-0656, Giancristofaro, Rosa Arboretti, Pilotto, Andrea ORCID: 0000-0003-2029-6606, Daragjati, Julia, Carrozzo, Eleonora, Prete, Camilla, Gallina, Pietro, Padovani, Alessandro and Maggi, Stefania (2018). Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment. J. Am. Med. Dir. Assoc., 19 (2). S. 162 - 169. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1538-9375

Full text not available from this repository.

Abstract

Objective: To evaluate whether treatment with antidementia drugs is associated with reduced mortality in older patients with different mortality risk at baseline. Design: Retrospective. Setting: Community-dwelling. Participants: A total of 6818 older people who underwent a Standardized Multidimensional Assessment Schedule for Adults and Aged Persons (SVaMA) evaluation to determine accessibility to homecare services or nursing home admission from 2005 to 2013 in the Padova Health District, Italy were included. Measurements: Mortality risk at baseline was calculated by the Multidimensional Prognostic Index (MPI), based on information collected with the SVaMA. Participants were categorized to have mild (MPI-SVaMA-1), moderate (MPI-SVaMA-2), and high (MPI-SVaMA-3) mortality risk. Propensity score-adjusted hazard ratios (HR) of 2-year mortality were calculated according to antidementia drug treatment. Results: Patients treated with antidementia drugs had a significant lower risk of death than untreated patients (HR 0.82; 95% confidence interval [CI] 0.73-0.92 and 0.56; 95% CI 0.49-0.65 for patients treated less than 2 years and more than 2 years treatment, respectively). After dividing patients according to their MPI-SVaMA grade, antidementia treatment was significantly associated with reduced mortality in the MPI-SVaMA-1 mild (HR 0.71; 95% CI 0.54-0.92) and MPI-SVaMA-2 moderate risk (HR 0.61; 95% CI 0.40-0.91, matched sample), but not in the MPI-SVaMA-3 high risk of death. Conclusions: This large community-dwelling patient study suggests that antidementia drugs might contribute to increased survival in older adults with dementia with lower mortality risk. (C) 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Pilotto, AlbertoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Polidori, Maria CristinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Veronese, NicolaUNSPECIFIEDorcid.org/0000-0002-9328-289XUNSPECIFIED
Panza, FrancescoUNSPECIFIEDorcid.org/0000-0002-7220-0656UNSPECIFIED
Giancristofaro, Rosa ArborettiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pilotto, AndreaUNSPECIFIEDorcid.org/0000-0003-2029-6606UNSPECIFIED
Daragjati, JuliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Carrozzo, EleonoraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Prete, CamillaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gallina, PietroUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Padovani, AlessandroUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maggi, StefaniaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-196561
DOI: 10.1016/j.jamda.2017.08.017
Journal or Publication Title: J. Am. Med. Dir. Assoc.
Volume: 19
Number: 2
Page Range: S. 162 - 169
Date: 2018
Publisher: ELSEVIER SCIENCE INC
Place of Publication: NEW YORK
ISSN: 1538-9375
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MULTIDIMENSIONAL PROGNOSTIC INDEX; COMPREHENSIVE GERIATRIC ASSESSMENT; CHOLINESTERASE-INHIBITORS; ALZHEIMER-DISEASE; MEMANTINE; DONEPEZIL; PEOPLE; ADULTS; VALIDATION; STATEMENTMultiple languages
Geriatrics & GerontologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/19656

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item